<DOC>
	<DOC>NCT02820506</DOC>
	<brief_summary>The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with high-risk histology endometrial cancer and in patients with cervical cancer tumour size 2-4 cm.</brief_summary>
	<brief_title>Sentinel Node Mapping in Women With Endometrial and Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>Study IIA: Patients with cervical cancer, FIGO IB1, tumor size 24 cm Study IIB: Patients with high risk endometrial cancer, presumed FIGO I, type 1 histology grade 3 Endometrioid adenocarcinoma or type 2 histology (serous, clearcel, carcinosarcoma or undifferentiated adenocarcinoma. Prior PL Known allergy towards ICG and/or iodine (ICG contains 5% sodium iodine) Women included in other studies affecting outcomemeasures of the present study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>robotic surgery procedures</keyword>
	<keyword>indocyanine green</keyword>
	<keyword>sentinel lymph node mapping</keyword>
</DOC>